Effects of consumption of the test food on bowel movement
- Conditions
- Healthy Japanese subjects
- Registration Number
- JPRN-UMIN000042783
- Lead Sponsor
- ORTHOMEDICO Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 88
Not provided
Subjects (who) 1.undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2.have a pacemaker or an implantable cardioverter defibrillator 3.currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4.take "Foods for Specified Health Uses", "Foods with Functional Claims", foods containing viable fungi such as natto, yogurt, and fermented foods, foods fortified with oligosaccharides and dietary fiber, foods containing high amounts of sugar alcohol, food/beverage containing lactic acid bacteria, or other functional food/beverage in daily use and unable to quit the intake during the test period 5.regularly use medicines related to bowel movement, such as intestinal regulator and laxatives 6.currently taking medicines (include herbal medicines) and supplements 7.affected from pollen allergy 8.have received vaccination for infectious diseases such as influenza within a year 9.are smokers, or started smoking cessation within a year 10.drink an excess of alcohol *weekly average of alcohol intake is more than 60 g/day [Reference materials for the promotion of Health Japan 21 (the second term)] 11.are planning to go abroad or have a job transfer during this trial 12.are allergic to medicines and/or the test food related products. Particularly, lactic acid bacteria, vitamin D, starch, sucrose fatty acid ester, or hydroxypropylmethylcellulose capsule 13.are lactating, pregnant, or intending to become pregnant 14.have been enrolled in other clinical trials within the last 3 months before the invitation to participate in this trial, or plan to participate in another trial during this trial 15.are judged by the principal investigator as ineligible to participate in the trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The measured value of defecation frequency at period VI
- Secondary Outcome Measures
Name Time Method